Skip to main content
Arun Swaminathan, MD, Neurology, Madison, WI

ArunSwaminathanMD

Neurology Madison, WI

Epilepsy, Neurophysiology

Physician

Dr. Swaminathan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Swaminathan's full profile

Already have an account?

  • Office

    700 S Park St
    Ste A
    Madison, WI 53715
    Phone+1 608-260-2900
    Fax+1 608-260-3444

Education & Training

  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemFellowship, Epilepsy, 2016 - 2018
  • University of Kentucky College of Medicine
    University of Kentucky College of MedicineResidency, Neurology, 2012 - 2016
  • L. Tilak Municipal Medical College
    L. Tilak Municipal Medical CollegeClass of 2010

Certifications & Licensure

  • WI State Medical License
    WI State Medical License 2022 - 2025
  • IA State Medical License
    IA State Medical License 2019 - 2023
  • SD State Medical License
    SD State Medical License Active through 2023
  • NE State Medical License
    NE State Medical License 2018 - 2022
  • PA State Medical License
    PA State Medical License 2016 - 2018
  • KY State Medical License
    KY State Medical License 2013 - 2017
  • American Board of Psychiatry and Neurology Neurology
  • American Board of Psychiatry and Neurology Epilepsy

Publications & Presentations

PubMed

Press Mentions

  • With Maverick Now in Takeda's Hands, James Scibetta Turns the Page; Roivant CMO Leaves in Favor of Small IL-2 Biotech
    With Maverick Now in Takeda's Hands, James Scibetta Turns the Page; Roivant CMO Leaves in Favor of Small IL-2 BiotechSeptember 24th, 2021
  • Alteogen Announces Completion of Phase 1 Clinical Trial of Aflibercept Biosimilar in Wet AMD Patients
    Alteogen Announces Completion of Phase 1 Clinical Trial of Aflibercept Biosimilar in Wet AMD PatientsMarch 8th, 2021
  • Dr Arun Swaminathan – University of Nebraska Medical Center
    Dr Arun Swaminathan – University of Nebraska Medical CenterMarch 3rd, 2021
  • Join now to see all